Navidea Biopharmaceuticals Inc (NAVB)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Navidea Biopharmaceuticals Inc (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012246
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used in intra-operative lymphatic mapping (ILM), external lymph node imaging (lymphoscintigraphy) and sentinel lymph node biopsy. The company’s products in pipeline includes lifecycle management of Lymphoseek; and NAV4694, a fluorine-18 PET (positron emission tomography) imaging agent, is being developed for the diagnosis of cognitive impairment and dementia, including Alzhemier’s disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, Israel and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc (NAVB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Navidea Raises USD50 Million in Venture Financing 11
Partnerships 12
BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12
Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13
Navidea Biopharm forms Joint Venture with Rheumco 14
Navidea Biopharma Enters into Agreement with University of California San Francisco 15
Licensing Agreements 16
Navidea Enters into License Agreement with Norgine for Lymphoseek 16
Equity Offering 17
Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 17
Asset Transactions 18
Cardinal Health Acquires Lymphoseek from Navidea Biopharma 18
Navidea Biopharmaceuticals Inc – Key Competitors 20
Navidea Biopharmaceuticals Inc – Key Employees 21
Navidea Biopharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 22
Recent Developments 23
Financial Announcements 23
Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results 23
Aug 08, 2017: Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results 25
May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results 26
Mar 29, 2017: Navidea Provides Corporate Update and Reports Full Year 2016 Results 28
Nov 03, 2016: Navidea Reports 2016 Third Quarter Financial Results 31
Aug 04, 2016: Navidea Reports Second Quarter 2016 Financial Results 33
May 17, 2016: Navidea Reports First Quarter 2016 Financial Results 36
Mar 23, 2016: Navidea Announces Fourth Quarter and Full Year 2015 Results 38
Corporate Communications 40
Sep 26, 2016: Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer 40
Apr 26, 2016: Navidea Appoints Jed Latkin as Interim Chief Operating Officer 41
Jan 11, 2016: Navidea Appoints Anton Gueth Chairman of the Board 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Navidea Biopharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Navidea Raises USD50 Million in Venture Financing 11
BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12
Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13
Navidea Biopharm forms Joint Venture with Rheumco 14
Navidea Biopharma Enters into Agreement with University of California San Francisco 15
Navidea Enters into License Agreement with Norgine for Lymphoseek 16
Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 17
Cardinal Health Acquires Lymphoseek from Navidea Biopharma 18
Navidea Biopharmaceuticals Inc, Key Competitors 20
Navidea Biopharmaceuticals Inc, Key Employees 21
Navidea Biopharmaceuticals Inc, Subsidiaries 22
Navidea Biopharmaceuticals Inc, Joint Venture 22

★海外企業調査レポート[Navidea Biopharmaceuticals Inc (NAVB)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lightbridge Corporation (LTBR):企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Acome:企業の戦略・SWOT・財務情報
    Acome - Strategy, SWOT and Corporate Finance Report Summary Acome - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Flowserve Corporation:企業の戦略・SWOT・財務分析
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cohu Inc (COHU):企業の財務・戦略的SWOT分析
    Cohu Inc (COHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Polo Resources Ltd (POL):石油・ガス:M&Aディール及び事業提携情報
    Summary Polo Resources Ltd (Polo Resources) is a natural resource and mine development investment company that evaluates, acquires, and develops substantial investments in companies and projects. The company also invests in exploration companies. It invests in the gold, oil and gas, coal, phosphate, …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mallinckrodt plc:企業の戦略・SWOT・財務情報
    Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report Summary Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pathogenica Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenica Inc (Pathogenica) is a medical device company that offers multiplex bacterial detection and genotyping kit. The company provides medical diagnostic sequencing products and services for research and clinical use. Its scientific consulting services offers experimental design, DxSeq …
  • Pakistan Petroleum Ltd (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adhi, Mazarani, Chachar, Adam, Adam West, Shahdadpur, Shahdadpur East and West. It also has working …
  • Pharnext SA (ALPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to ident …
  • Omnicell Inc (OMCL)-医療機器分野:企業M&A・提携分析
    Summary Omnicell Inc (Omnicell) is a provider of automation and business analytics software solutions. It provides medication control and patient safety solutions to enhance operational efficiency and patient care in acute healthcare facilities. The company offers automation solutions such as medica …
  • Alpiq Holding AG:企業の戦略的SWOT分析
    Alpiq Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sanara MedTech Inc (WNDM):企業の財務・戦略的SWOT分析
    Summary Sanara MedTech Inc (Sanara MedTech), formerly WNDM Medical Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its pro …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • WideMed Technologies LTD:医療機器:M&Aディール及び事業提携情報
    Summary WideMed Technologies LTD (WideMed) is a medical device company that develops and manufactures information systems for monitoring, diagnosis and analysis of sleep disorders. The company’s products include Morpheus Modules, Morpheus Hx and Morpheus Ox. Its Morpheus modules are automatic scorin …
  • Casio Computer Co Ltd (6952):企業の財務・戦略的SWOT分析
    Casio Computer Co Ltd (6952) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vonage Holdings Corp.:戦略・SWOT・企業財務分析
    Vonage Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆